-
1
-
-
0037160968
-
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol
-
Dahlof B, Devereux RB, Kjeldsen SE, et al. for the LIFE study group. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002;359:995-1003.
-
(2002)
Lancet
, vol.359
, pp. 995-1003
-
-
Dahlof, B.1
Devereux, R.B.2
Kjeldsen, S.E.3
-
2
-
-
0037160969
-
Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol
-
Lindholm LH, Ibsen H, Dahlof B, et al. for the LIFE study group. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002;359:1004-10.
-
(2002)
Lancet
, vol.359
, pp. 1004-1010
-
-
Lindholm, L.H.1
Ibsen, H.2
Dahlof, B.3
-
3
-
-
0037149716
-
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction
-
Moss AJ, Zareba W, Hall J, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346(12):877-83.
-
(2002)
N Engl J Med
, vol.346
, Issue.12
, pp. 877-883
-
-
Moss, A.J.1
Zareba, W.2
Hall, J.3
-
4
-
-
0037149720
-
Expanding indications for implantable cardiac defibrillators
-
Bigger JT. Expanding indications for implantable cardiac defibrillators. N Engl J Med 2002;346(12):931-3.
-
(2002)
N Engl J Med
, vol.346
, Issue.12
, pp. 931-933
-
-
Bigger, J.T.1
-
5
-
-
0036152652
-
Outcome studies with device therapy in patients with heart failure
-
Cleland JGF, Thackray S, Goodge L, Kaye G, Cooklin M. Outcome studies with device therapy in patients with heart failure. J Cardiovasc Electrophysiol 2002;13:S73-91.
-
(2002)
J Cardiovasc Electrophysiol
, vol.13
-
-
Cleland, J.G.F.1
Thackray, S.2
Goodge, L.3
Kaye, G.4
Cooklin, M.5
-
6
-
-
0037028893
-
Implantable defibrillator event rates in patients with idiopathic dilated cardiomyopathy, nonsustained ventricular tachycardia on Holter and a left ventricular ejection fraction below 30%
-
Mar 6
-
Grimm W, Hoffmann JJ, Muller HH, Maisch B. Implantable defibrillator event rates in patients with idiopathic dilated cardiomyopathy, nonsustained ventricular tachycardia on Holter and a left ventricular ejection fraction below 30%. J Am Coll Cardiol, Mar 6 2002;39(5):780-7.
-
(2002)
J Am Coll Cardiol
, vol.39
, Issue.5
, pp. 780-787
-
-
Grimm, W.1
Hoffmann, J.J.2
Muller, H.H.3
Maisch, B.4
-
7
-
-
0034831901
-
Clinical trials update: CAPRICORN, COPERNICUS, MIRACLE, STAF, RITZ-2, RECOVER, RENAISSANCE and cachexia and cholesterol in heart failure. Highlights of the Scientific Sessions of the American College of Cardiology 2001
-
Louis A, Cleland JGF, Crabbe S, Ford S, Thackray S, Houghton T, Clark A. Clinical trials update: CAPRICORN, COPERNICUS, MIRACLE, STAF, RITZ-2, RECOVER, RENAISSANCE and cachexia and cholesterol in heart failure. Highlights of the Scientific Sessions of the American College of Cardiology 2001. Eur J Heart Fail 2001;3:381-7.
-
(2001)
Eur J Heart Fail
, vol.3
, pp. 381-387
-
-
Louis, A.1
Cleland, J.G.F.2
Crabbe, S.3
Ford, S.4
Thackray, S.5
Houghton, T.6
Clark, A.7
-
8
-
-
4244154167
-
Why ICD patients with heart failure (Class II-IV) are hospitalized: Do the reasons differ for patients who are treated with cardiac resynchronisation therapy?
-
Boehmer JP, DeMarco T, Jaski BE, Carlsen MD, Rathbun VL, Schmeichel CN. Why ICD patients with heart failure (Class II-IV) are hospitalized: Do the reasons differ for patients who are treated with cardiac resynchronisation therapy? JACC 2002;39:159A.
-
(2002)
JACC
, vol.39
-
-
Boehmer, J.P.1
DeMarco, T.2
Jaski, B.E.3
Carlsen, M.D.4
Rathbun, V.L.5
Schmeichel, C.N.6
-
9
-
-
0034888581
-
Clinical trials update: Highlights of the Scientific Sessions of Heart Failure 2001, a meeting of the Working Group on Heart Failure of the European Society of Cardiology. CONTAK-CD, CHRISTMAS, OPTIME-CHF
-
Thackray S, Coletta A, Jones P, Dunn A, Clark AL, Cleland JGF. Clinical trials update: Highlights of the Scientific Sessions of Heart Failure 2001, a meeting of the Working Group on Heart Failure of the European Society of Cardiology. CONTAK-CD, CHRISTMAS, OPTIME-CHF. Eur J Heart Fail 2001;3:491-4.
-
(2001)
Eur J Heart Fail
, vol.3
, pp. 491-494
-
-
Thackray, S.1
Coletta, A.2
Jones, P.3
Dunn, A.4
Clark, A.L.5
Cleland, J.G.F.6
-
10
-
-
0033534085
-
Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure
-
Packer M, Poole Wilson PA, Armstrong PW, et al. on behalf of the ATLAS investigators. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. Circulation 1999;100:2312-8.
-
(1999)
Circulation
, vol.100
, pp. 2312-2318
-
-
Packer, M.1
Poole Wilson, P.A.2
Armstrong, P.W.3
-
11
-
-
0033498214
-
The carvedilol hibernation reversible ischaemia trial: Marker of success (CHRISTMAS)
-
Cleland JGF, Pennell DJ, Ray S, et al. and The CHRISTMAS Study Steering Committee and Investigators, The Carvedilol Hibernation Reversible Ischaemia Trial: marker of success (CHRISTMAS). Eur J Heart Fail 1999;1:191-6.
-
(1999)
Eur J Heart Fail
, vol.1
, pp. 191-196
-
-
Cleland, J.G.F.1
Pennell, D.J.2
Ray, S.3
-
13
-
-
0034124255
-
Systematic review of the management of atrial fibrillation in patients with heart failure
-
Khand A, Rankin AC, Kaye GC, Cleland JGF. Systematic review of the management of atrial fibrillation in patients with heart failure. Eur Heart J 2000;21:614-32.
-
(2000)
Eur Heart J
, vol.21
, pp. 614-632
-
-
Khand, A.1
Rankin, A.C.2
Kaye, G.C.3
Cleland, J.G.F.4
-
14
-
-
0035892018
-
Long term use of a left ventricular assist device for end-stage heart failure
-
Rose EA, Gelijns AC, Moskowitz AJ, et al. for the randomised evaluation of mechanical assistance for the treatment of congestive heart failure (REMATCH) study group. Long term use of a left ventricular assist device for end-stage heart failure. N Eng J Med 2001;345:1435-43.
-
(2001)
N Eng J Med
, vol.345
, pp. 1435-1443
-
-
Rose, E.A.1
Gelijns, A.C.2
Moskowitz, A.J.3
|